The importance of pleural fluid and serum NT-proBNP levels in differentiating pleural effusion due to heart failure from other causes of effusion

Internal Medicine

Volumn 48, Issue 5, 2009, Pages 287-293

  Seyhan, Ekrem Cengiz ^a   Altin, Sedat ^a   Cetinkaya, Erdogan ^a   Sokucu, Sinem ^a   Gunluoglu, Mehmet Zeki ^a   Demir, Adalet ^a   Korkmaz, Pelin ^a   Issever, Halim ^b  

^a Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Congestive heart failure; Natriuretic peptides; Pleural effusion; Serum pleural fluid albumin gradients

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EFFUSION; ELECTROCHEMISTRY; FEMALE; HUMAN; IMMUNOASSAY; INFECTIOUS EFFUSION; LIGHT CRITERIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT EFFUSION; PARAPNEUMONIC EFFUSION; PLEURA EFFUSION; PLEURA FLUID; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TUBERCULOSIS EFFUSION; BLOOD; DIFFERENTIAL DIAGNOSIS; HEART FAILURE; METABOLISM; MIDDLE AGED; PLEURA CAVITY; PROSPECTIVE STUDY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PLEURAL CAVITY; PLEURAL EFFUSION; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 66149172392     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1607     Document Type: Article

References (23)

1. Marel M, Zrustova M, Stastny B, Light RW. The incidence of pleural effusion in a well-defined region: epidemiologic study in central Bohemia. Chest 104: 1486-1489, 1993.
2. Chakko SC, Caldwell SH, Sforza PP. Treatment of conjestive heart failure: its effect on pleural fluid chemistry. Chest 95: 978-982, 1989.
3. Shinto RA, Light RW. The effects of diuresis upon the characteristics of pleural fluid in patients with congestive heart failure. Am Rev Respir Dis 137: 458, 1988.
4. Bartter T, Santarelli R, Akers SM, Pratter MR. The evaluation of pleural effusion. Chest 106: 1209-1214, 1994.
5. Light RW, MacGregor MI, Ball WC Jr, Luchsinger PC. Pleural effusion: the diagnostic separation of transudates and exudates. Ann Intern Med 77: 507-513, 1972.
6. Roth BJ, O'Meara TF, Cragun WH. The serum-effusion albumin gradient in the evaluation of pleural effusion. Chest 98: 546-549, 1990.
7. Romero S, Candela A, Martin C, Hernandez L, Trigo C, Gil J. Evaluation of different criteria for the separation of pleural transudates from exudates. Chest 104: 399-404, 1993.
8. Eid AA, Keddissi JI, Samaha M, Tawk MM, Kimmell K, Kinasewitz GT. Exudative effusion in congestive heart failure. Chest 122: 1518-1523, 2002.
9. McCullough PA, Omland T, Maisel AS. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 4: 72-80, 2003.
10. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Diagnostic accuracy of B-type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91: 606-612, 2005.
11. Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7: 21-29, 2001.
12. Tomcsanyi J, Nagy E, Somloi M, Moldvay J, Bezzegh A, Bozsik B, Strausz J. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur J Heart Fail 6: 753-756, 2004.
13. Gegenhuber A, Mueller T, Dieplinger B, Lenz K, Poelz W, Haltmayers M. Plasma B-type natriuretic peptide in patients with pleural effusion: preliminary observations. Chest 128: 1003-1009, 2005.
14. Kolditz M, Halank M, Schiemanck CS, Schmeisser G, Hoffken G. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusion. Eur Respir J 28: 144-150, 2006.
15. Porcel JM, Vives M, Cao G, Esquerda A, Rubio M, Rivas MC. Measurement of probrain natriuretic peptidein pleural fluid for the diagnosis of pleural effusion due to heart failure. Am J Med 116: 417-420, 2004.
16. Porcel JM, Chorda J, Cao G, Esquerda A, Ruiz-Gonzales A, Vives M. Comparing serum and pleural fluid pro-brain natriuretic peptide levels with pleural- serum albumin gradient for the identification of cardiaceffusion misclassified by Light's criteria. Respirology 12: 654-659, 2007.
17. Liao H, NA Moon J, Dikensoy O, Lane KB, Randal B, Light RW. Diagnostic value of pleural fluid N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases. Respirology 13: 53-57, 2008.
18. Berkowitz R. B-type natriuretic peptide and the diagnosis of acute heart failure. Rev Cardiovasc Med 5: 3-16, 2004.
19. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 76: 232-237, 1996.
20. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide (BNP) predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39: 131-138, 2002.
21. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161-167, 2002.
22. McDonough TA, Holmer S, Raymond I, et al. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 6: 269-273, 2004.
23. Romero S, Candela A, Martin C, et al. Influence of diuretics on the concentration of protein and other components of pleural transudates with heart failure. Am J Med 110: 681-686, 2001.